Skye Bioscience:合并后公司现金储备预计可支撑运营至2029年,Rxc008二期数据预计2028年下半年公布

美股速递
Aug 14

Skye Bioscience Inc. 宣布,合并后的公司现金储备预计将足以维持运营至2029年。同时,其核心药物候选Rxc008的二期临床数据,预计将在2028年下半年对外公布。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10